Personas / Equipo Humano

Angel Montero Carcaboso

Buscador de publicaciones

Publicaciones

  • Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Gene-Olaciregui N, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM and Helin K.

    EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas

    NATURE MEDICINE . 23(4): 483-492. Nº de citas: 390

    [doi:10.1038/nm.4293]

  • Monterrubio C, Paco-Mercader S, Gene-Olaciregui N, Pascual-Pastó G, Vilà-Ubach M, Cuadrado-Vilanova M, Ferrandiz MM, Castillo-Ecija H, Glisoni R, Kuplennik N, Jungbluth A, de Torres C, Lavarino C, Cheung NV, Mora J, Sosnik A and Carcaboso AM.

    Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

    JOURNAL OF CONTROLLED RELEASE . 255: 108-119. Nº de citas: 35

    [doi:10.1016/j.jconrel.2017.04.016]

  • Hennika T, Hu G, Gene-Olaciregui N, Barton KL, Ehteda A, Chitranjan A, Chang C, Gifford AJ, Tsoli M, Ziegler DS, Carcaboso AM and Becher OJ.

    Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models

    PLoS One . 12(1): . Nº de citas: 130

    [doi:10.1371/journal.pone.0169485]

  • Fang X, Zhou W, Wu Q, Huang Z, Shi Y, Yang K, Chen C, Xie Q, Mack SC, Wang X, Carcaboso AM, Sloan AE, Ouyang G, McLendon RE, Bian XW, Rich JN and Bao S.

    Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

    JOURNAL OF EXPERIMENTAL MEDICINE . 214(1): 245-267. Nº de citas: 121

    [doi:10.1084/jem.20151673]

  • Pascual-Pastó G, Gene-Olaciregui N, Vilà-Ubach M, Paco-Mercader S, Monterrubio C, Rodriguez E, Winter U, Batalla-Vilacís M, Català-Mora J, Salvador-Hernandez H, Parareda A, Schaiquevich P, Suñol M, Mora J, Lavarino C, de Torres C, Chantada G and Carcaboso AM.

    Preclinical platform of retinoblastoma xenografts recapitulating human disease and molecular markers of dissemination

    CANCER LETTERS . 380(1): 10-19. Nº de citas: 25

    [doi:10.1016/j.canlet.2016.06.012]

  • Jansen MH, Lagerweij T, Sewing AC, Vugts DJ, van Vuurden DG, Molthoff CF, Caretti V, Veringa SJ, Petersen N, Carcaboso AM, Noske DP, Vandertop WP, Wesseling P, van Dongen GA, Kaspers GJ and Hulleman E.

    Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models

    MOLECULAR CANCER THERAPEUTICS . 15(9): 2166-2174. Nº de citas: 50

    [doi:10.1158/1535-7163.MCT-15-0558]

  • Winter U, Mena HA, Negrotto S, Arana E, Pascual-Pastó G, Laurent V, Suñol M, Chantada G, Carcaboso AM and Schaiquevich P.

    Schedule-Dependent Antiangiogenic and Cytotoxic Effects of Chemotherapy on Vascular Endothelial and Retinoblastoma Cells

    PLoS One . 11(7): . Nº de citas: 21

    [doi:10.1371/journal.pone.0160094]

  • Hernandez-Muñoz I, Figuerola-Bou E, Sánchez-Molina S, Rodriguez E, Fernández-Mariño AI, Pardo-Pastor C, Bahamonde MI, Fernández-Fernández JM, García-Domínguez DJ, Hontecillas-Prieto L, Lavarino C, Carcaboso AM, de Torres C, Tirado OM, de Alava E and Mora J.

    RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-?B pathway, independently of the fusion oncoprotein

    Oncotarget . 7(29): 46283-46300. Nº de citas: 12

    [doi:10.18632/oncotarget.10092]

  • Rodriguez-Hernandez CJ, Mateo-Lozano S, Garcia-López M, Casalà C, Briansó F, Castrejon N, Rodriguez E, Suñol M, Carcaboso AM, Lavarino C, Mora J and de Torres C.

    Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens

    Oncotarget . 7(13): 16112-16129. Nº de citas: 17

    [doi:10.18632/oncotarget.7448]

  • Monterrubio C, Pascual-Pastó G, Cano F, Vilà-Ubach M, Manzanares-Quintela A, Schaiquevich P, Tornero JA, Sosnik A, Mora J and Carcaboso AM.

    SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery

    Biomaterials . 79: 69-78. Nº de citas: 42

    [doi:10.1016/j.biomaterials.2015.11.055]